Yoshii and colleagues represented exosomes secreted from TP53-deficient colon cancer cell line HCT116, which stimulate fibroblast-mediated tumor growth by suppressing TP53 activity in fibroblasts. This evidence concerns the gene TP53 and malignant colon neoplasm.